Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01530 3SBIO
RTNominal unchange5.660 0.000 (0.000%)
Others

23/08/2019 14:52

{I-bank focus}Morgan lowers 3SBio Inc (01530) to HK$16

[ET Net News Agency, 23 August 2019] Morgan Stanley lowered its target price for 3SBio
Inc (01530) to HK$16 from HK$17 to reflect lower RMB/HKD rate and lower sales guidance for
key products in 2019. The research house maintained its "overweight" rating.
Morgan said 3SBio's 1H sales were in line while normalized profit beat its estimates.
2019 full-year profit guidance intact despite lower sales guidance for Yisaipu and EPO.
With the NDRL (National Drug Reimbursement List) revision, Morgan thinks the guidance of
20-25% growth for sales and 20% for profit in 2019-20 is achievable. (KL)

Back to Others

Remark: Real time quote last updated: 19/04/2024 09:22
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.